Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment

por Badie, C, Dziwura, S, Raffy, C, Tsigani, T, Alsbeih, G, Moody, J, Finnon, P, Levine, E, Scott, D, Bouffler, S
Publicado 2008

Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance

por Leung, E L, Fraser, M, Fiscus, R R, Tsang, B K
Publicado 2008

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

por Whittemore, A S, Balise, R R, Pharoah, P D P, DiCioccio, R A, Oakley-Girvan, I, Ramus, S J, Daly, M, Usinowicz, M B, Garlinghouse-Jones, K, Ponder, B A J, Buys, S, Senie, R, Andrulis, I, John, E, Hopper, J L, Piver, M S
Publicado 2004

Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci

por Brown, W M, Lange, E M, Chen, H, Zheng, S L, Chang, B, Wiley, K E, Isaacs, S D, Walsh, P C, Isaacs, W B, Xu, J, Cooney, K A
Publicado 2004

CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes

por Schmidt, R, Baumann, F, Knüpfer, H, Brauckhoff, M, Horn, L-C, Schönfelder, M, Köhler, U, Preiss, R
Publicado 2004

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

por Bhat-Nakshatri, P, Campbell, R A, Patel, N M, Newton, T R, King, A J, Marshall, M S, Ali, S, Nakshatri, H
Publicado 2004

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

por Pontisso, P, Calabrese, F, Benvegnù, L, Lise, M, Belluco, C, Ruvoletto, M G, De Falco, S, Marino, M, Valente, M, Nitti, D, Gatta, A, Fassina, G
Publicado 2004

Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma

por Lotem, M, Shiloni, E, Pappo, I, Drize, O, Hamburger, T, Weitzen, R, Isacson, R, Kaduri, L, Merims, S, Frankenburg, S, Peretz, T
Publicado 2004

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells

por Morimoto, Y, Toyota, M, Satoh, A, Murai, M, Mita, H, Suzuki, H, Takamura, Y, Ikeda, H, Ishida, T, Sato, N, Tokino, T, Imai, K
Publicado 2004

A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer

por Guppy, A E, Nelstrop, A E, Foster, T, Agarwal, R, Seckl, M J, Rustin, G J S
Publicado 2004

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced...

por Bartlett, J B, Michael, A, Clarke, I A, Dredge, K, Nicholson, S, Kristeleit, H, Polychronis, A, Pandha, H, Muller, G W, Stirling, D I, Zeldis, J, Dalgleish, A G
Publicado 2004

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

por Bleumer, I, Knuth, A, Oosterwijk, E, Hofmann, R, Varga, Z, Lamers, C, Kruit, W, Melchior, S, Mala, C, Ullrich, S, Mulder, P De, Mulders, P F A, Beck, J
Publicado 2004

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy

por Gennari, A, Bruzzi, P, Orlandini, C, Salvadori, B, Donati, S, Landucci, E, Guarneri, V, Rondini, M, Ricci, S, Conte, P
Publicado 2004

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

por Lantuejoul, S, Soria, J C, Moro-Sibilot, D, Morat, L, Veyrenc, S, Lorimier, P, Brichon, P Y, Sabatier, L, Brambilla, C, Brambilla, E
Publicado 2004

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

por McNeish, I A, Kanfer, E J, Haynes, R, Giles, C, Harland, S J, Driver, D, Rustin, G J S, Newlands, E S, Seckl, M J
Publicado 2004

Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?

por Sainsbury, R
Publicado 2004

Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations

por Menzel, H-J, Sarmanova, J, Soucek, P, Berberich, R, Grünewald, K, Haun, M, Kraft, H-G
Publicado 2004

Somatic mutations of KIT in familial testicular germ cell tumours

por Rapley, E A, Hockley, S, Warren, W, Johnson, L, Huddart, R, Crockford, G, Forman, D, Leahy, M G, Oliver, D T, Tucker, K, Friedlander, M, Phillips, K-A, Hogg, D, Jewett, M A S, Lohynska, R, Daugaard, G, Richard, S, Heidenreich, A, Geczi, L, Bodrogi, I, Olah, E, Ormiston, W J, Daly, P A, Looijenga, L H J, Guilford, P, Aass, N, Fosså, S D, Heimdal, K, Tjulandin, S A, Liubchenko, L, Stoll, H, Weber, W, Einhorn, L, Weber, B L, McMaster, M, Greene, M H, Bishop, D T, Easton, D, Stratton, M R
Publicado 2004

High levels of untreated distress and fatigue in cancer patients

por Carlson, L E, Angen, M, Cullum, J, Goodey, E, Koopmans, J, Lamont, L, MacRae, J H, Martin, M, Pelletier, G, Robinson, J, Simpson, J S A, Speca, M, Tillotson, L, Bultz, B D
Publicado 2004

β(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients

por Shrout, J, Yousefzadeh, M, Dodd, A, Kirven, K, Blum, C, Graham, A, Benjamin, K, Hoda, R, Krishna, M, Romano, M, Wallace, M, Garrett-Mayer, E, Mitas, M
Publicado 2008